JPWO2019208718A1 - 脂質濃度計測装置及びその方法 - Google Patents
脂質濃度計測装置及びその方法 Download PDFInfo
- Publication number
- JPWO2019208718A1 JPWO2019208718A1 JP2020515579A JP2020515579A JPWO2019208718A1 JP WO2019208718 A1 JPWO2019208718 A1 JP WO2019208718A1 JP 2020515579 A JP2020515579 A JP 2020515579A JP 2020515579 A JP2020515579 A JP 2020515579A JP WO2019208718 A1 JPWO2019208718 A1 JP WO2019208718A1
- Authority
- JP
- Japan
- Prior art keywords
- light intensity
- light
- intensity
- lipid concentration
- unit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000002632 lipids Chemical class 0.000 title claims abstract description 165
- 238000000034 method Methods 0.000 title claims description 34
- 238000001514 detection method Methods 0.000 claims abstract description 83
- 210000004369 blood Anatomy 0.000 claims abstract description 61
- 239000008280 blood Substances 0.000 claims abstract description 61
- 239000002245 particle Substances 0.000 claims description 49
- 238000004364 calculation method Methods 0.000 claims description 34
- 230000017531 blood circulation Effects 0.000 claims description 30
- 238000004891 communication Methods 0.000 claims description 24
- 238000000149 argon plasma sintering Methods 0.000 claims description 6
- 230000001678 irradiating effect Effects 0.000 claims description 6
- 238000005259 measurement Methods 0.000 abstract description 21
- 238000010586 diagram Methods 0.000 abstract description 13
- 108090001030 Lipoproteins Proteins 0.000 description 18
- 102000004895 Lipoproteins Human genes 0.000 description 18
- 108010004103 Chylomicrons Proteins 0.000 description 12
- 238000012360 testing method Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 230000000291 postprandial effect Effects 0.000 description 7
- 238000011088 calibration curve Methods 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- 208000031226 Hyperlipidaemia Diseases 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 230000002238 attenuated effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 230000010349 pulsation Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 102000006410 Apoproteins Human genes 0.000 description 1
- 108010083590 Apoproteins Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4738—Diffuse reflection, e.g. also for testing fluids, fibrous materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4866—Evaluating metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/06—Investigating concentration of particle suspensions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/39—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using tunable lasers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/49—Scattering, i.e. diffuse reflection within a body or fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0233—Special features of optical sensors or probes classified in A61B5/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/06—Investigating concentration of particle suspensions
- G01N15/075—Investigating concentration of particle suspensions by optical means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/06—Investigating concentration of particle suspensions
- G01N2015/0687—Investigating concentration of particle suspensions in solutions, e.g. non volatile residue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/39—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using tunable lasers
- G01N2021/392—Measuring reradiation, e.g. fluorescence, backscatter
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N2021/4704—Angular selective
- G01N2021/4709—Backscatter
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Obesity (AREA)
- Dispersion Chemistry (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Description
(数式1)
μs’=R(ρ1) / R(ρ2)
制御部24は、複数の光強度検出部23により検出された光強度の差から散乱係数μs’を算出する。光強度比算出と同様、照射した光が、検出位置233までの距離を遠くするにつれて散乱により減衰していく散乱現象に基づき散乱係数μs’を算出する。
(数式2)
μs’=R(ρ1) - R(ρ2)
なお、制御部24による散乱係数μs’の算出方法は、上記の各算出によるものに限定されない。
12 照射部
13 光強度検出部
14 乱流強度算出部
15 脂質濃度算出部
Claims (13)
- 生体に所定の光強度で光を照射する照射部と、
前記照射部から所定の距離に位置し、前記生体から放出される光強度を検出する光強度検出部と、
前記光強度に基づき血流の乱流強度を算出し、
前記乱流強度から脂質濃度を算出する制御部と、
を有することを特徴とする脂質濃度計測装置。 - 前記照射部と前記光強度検出部の距離は、1.5cm以上2.0cm以下であることを特徴とする請求項1に記載の脂質濃度計測装置。
- 前記脂質は、CM、または、VLDLであることを特徴とする請求項1または2に記載の脂質濃度計測装置。
- 生体に所定の光強度で光を照射する照射部と、
前記照射部から所定間隔をあけて、あるいは、連続的に配置されて、あるいは、対面に配置されて、前記生体から放出される光強度を検出する光強度検出部と、
前記光強度に基づき生体内における光の散乱係数を算出し、
前記散乱係数に基づき血流の乱流強度を算出し、
前記乱流強度から脂質濃度を算出する制御部と、
を有することを特徴とする脂質濃度計測装置。 - 前記照射位置と前記光強度を検出する検出位置とが所定の照射検出間距離を隔てて設けられており、前記光強度検出部が血液内の脂質により散乱された後方散乱光による光強度を検出することを特徴とする請求項5に記載の脂質濃度計測装置。
- 前記照射部が連続光を発する光源であり、前記光源から光を照射するとともに、その照射位置を略中心として各々異なる距離に設置された複数の前記光強度検出部により各々の検出位置における光強度を検出し、
前記制御部は、各々の前記光強度検出部により検出された前記各々の光強度の比、又は、前記各々の光強度の差、に基づいて生体内における光の散乱係数を算出することを特徴とする請求項5または6に記載の脂質濃度計測装置。 - 前記制御部は、
前記散乱係数の変化量に基づき生体内における脂質の平均粒子径の変化量を算出し、
前記脂質の平均粒子径の変化量が80nm以上である場合に、前記乱流強度を算出する、ことを特徴とする請求項5から8のいずれかに記載の脂質濃度計測装置。 - 生体に所定の光強度で光を照射する照射部と、前記照射部から所定の距離に位置し、前記生体から放出される光強度を検出する光強度検出部と、前記光強度検出部により検出された光強度を送信する通信部とを有する第1装置に、通信可能に接続される脂質濃度計測装置であって、
前記第1装置から送信された前記光強度に基づき血流の乱流強度を算出し、
前記乱流強度から脂質濃度を算出する制御部、
を、有することを特徴とする脂質濃度計測装置。 - 生体に所定の光強度で光を照射する照射部と、前記照射部から所定間隔をあけて、あるいは、連続的に配置されて、あるいは、対面に配置されて、前記生体から放出される光強度を検出する光強度検出部と、前記光強度を送信する通信部とを有する第1装置に、通信可能に接続される脂質濃度計測装置であって、
前記第1装置から送信された前記光強度に基づき生体内における光の散乱係数を算出し、
前記散乱係数に基づき血流の乱流強度を算出し、
前記乱流強度から脂質濃度を算出する制御部、
を有することを特徴とする脂質濃度計測装置。 - 生体に所定の光強度で光を照射する照射工程と、
前記照射工程による光の照射位置から所定の距離の位置の前記生体から放出される光強度を検出する光強度検出工程と、
前記光強度に基づき血流の乱流強度を算出する乱流強度算出工程と、
前記乱流強度から脂質濃度を算出する脂質濃度算出工程と、
を有することを特徴とする脂質濃度計測方法。 - 生体に所定の光強度で光を照射する照射工程と、
前記照射工程による光の照射位置から所定間隔をあけて、あるいは、連続的に配置されて、あるいは、対面に配置されて、前記生体から放出される光強度を検出する光強度検出工程と、
前記光強度に基づき生体内における光の散乱係数を算出する散乱係数算出工程と、
前記散乱係数に基づき血流の乱流強度を算出する乱流強度算出工程と、
前記乱流強度から脂質濃度を算出する脂質濃度算出工程と、
を有することを特徴とする脂質濃度計測方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018085622 | 2018-04-26 | ||
JP2018085622 | 2018-04-26 | ||
PCT/JP2019/017746 WO2019208718A1 (ja) | 2018-04-26 | 2019-04-25 | 脂質濃度計測装置及びその方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2019208718A1 true JPWO2019208718A1 (ja) | 2021-05-27 |
Family
ID=68294056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020515579A Pending JPWO2019208718A1 (ja) | 2018-04-26 | 2019-04-25 | 脂質濃度計測装置及びその方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210059575A1 (ja) |
EP (1) | EP3741300A4 (ja) |
JP (1) | JPWO2019208718A1 (ja) |
KR (1) | KR20210004952A (ja) |
CN (1) | CN112040867A (ja) |
WO (1) | WO2019208718A1 (ja) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0889500A (ja) * | 1993-12-16 | 1996-04-09 | Iss Usa Inc | 複数光源を備えた光センサー |
JPH10258036A (ja) * | 1997-03-19 | 1998-09-29 | Matsushita Electric Ind Co Ltd | 血糖計 |
WO2017119130A1 (ja) * | 2016-01-08 | 2017-07-13 | 株式会社三菱ケミカルホールディングス | 非侵襲型生体脂質計測器及び非侵襲型生体脂質計測方法 |
WO2017141895A1 (ja) * | 2016-02-18 | 2017-08-24 | メディカルフォトニクス株式会社 | 体調管理装置及びその方法 |
WO2017199492A1 (ja) * | 2016-05-18 | 2017-11-23 | メディカルフォトニクス株式会社 | 血中脂質濃度計測装置及びその作動方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6635491B1 (en) * | 2000-07-28 | 2003-10-21 | Abbott Labortories | Method for non-invasively determining the concentration of an analyte by compensating for the effect of tissue hydration |
US7758744B2 (en) * | 2001-10-05 | 2010-07-20 | Stephen Eliot Zweig | Dual glucose-turbidimetric analytical sensors |
JP5924658B2 (ja) * | 2011-09-27 | 2016-05-25 | セイコーエプソン株式会社 | 濃度定量装置、光吸収係数算出方法、等価散乱係数算出方法、濃度定量方法、光吸収係数の算出を行うプログラム及び濃度の算出を行うプログラム |
US10188328B2 (en) * | 2012-12-06 | 2019-01-29 | National University Corporation Hokkaido University | Non-invasive biolipid concentration meter, non-invasive biolipid metabolism measuring device, non-invasive method for measuring biolipid concentration, and non-invasive method for examining biolipid metabolism |
WO2016041073A1 (en) * | 2014-09-17 | 2016-03-24 | 2352409 Ontario Inc. | Device and method for monitoring fat balance |
EP3988015A1 (en) * | 2017-02-14 | 2022-04-27 | Medical Photonics Co., Ltd. | Scatterer measuring apparatus |
EP3884864A1 (en) * | 2018-11-21 | 2021-09-29 | Medical Photonics Co., Ltd. | Device for measuring blood lipid concentration and method therefor |
-
2019
- 2019-04-25 CN CN201980027912.9A patent/CN112040867A/zh active Pending
- 2019-04-25 EP EP19793132.2A patent/EP3741300A4/en not_active Withdrawn
- 2019-04-25 WO PCT/JP2019/017746 patent/WO2019208718A1/ja unknown
- 2019-04-25 US US16/970,040 patent/US20210059575A1/en not_active Abandoned
- 2019-04-25 JP JP2020515579A patent/JPWO2019208718A1/ja active Pending
- 2019-04-25 KR KR1020207024545A patent/KR20210004952A/ko not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0889500A (ja) * | 1993-12-16 | 1996-04-09 | Iss Usa Inc | 複数光源を備えた光センサー |
JPH10258036A (ja) * | 1997-03-19 | 1998-09-29 | Matsushita Electric Ind Co Ltd | 血糖計 |
WO2017119130A1 (ja) * | 2016-01-08 | 2017-07-13 | 株式会社三菱ケミカルホールディングス | 非侵襲型生体脂質計測器及び非侵襲型生体脂質計測方法 |
WO2017141895A1 (ja) * | 2016-02-18 | 2017-08-24 | メディカルフォトニクス株式会社 | 体調管理装置及びその方法 |
WO2017199492A1 (ja) * | 2016-05-18 | 2017-11-23 | メディカルフォトニクス株式会社 | 血中脂質濃度計測装置及びその作動方法 |
Also Published As
Publication number | Publication date |
---|---|
EP3741300A1 (en) | 2020-11-25 |
CN112040867A (zh) | 2020-12-04 |
US20210059575A1 (en) | 2021-03-04 |
WO2019208718A1 (ja) | 2019-10-31 |
EP3741300A4 (en) | 2022-01-26 |
KR20210004952A (ko) | 2021-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11000214B2 (en) | Physical condition management device and method for same | |
WO2020105682A1 (ja) | 血中脂質濃度計測装置及びその方法 | |
WO2019225612A1 (ja) | 血管検知装置及びその方法 | |
JP6894088B2 (ja) | 散乱体濃度計測装置及びその方法 | |
TWI770119B (zh) | 散射體測量裝置及其方法 | |
TWI773713B (zh) | 脂質測量裝置及其方法 | |
JPWO2019208718A1 (ja) | 脂質濃度計測装置及びその方法 | |
JP6894087B2 (ja) | 脂質計測装置及びその方法 | |
JP2022149431A (ja) | 総蛋白濃度計測装置及びその方法 | |
JP2024046202A (ja) | 総蛋白濃度計測装置及び方法 | |
JP2024044393A (ja) | 総蛋白濃度計測装置及び方法 | |
WO2022138902A1 (ja) | 脂質濃度計測装置、プログラム、及び、方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE Effective date: 20200814 Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20200814 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20211102 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220614 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220810 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20221206 |